Trastuzumab and Pertuzumab Produce Changes in Morphology and Estrogen Receptor Signaling in Ovarian Cancer Xenografts Revealing New Treatment Strategies-Reference-Cited by-同舟云学术

Trastuzumab and Pertuzumab Produce Changes in Morphology and Estrogen Receptor Signaling in Ovarian Cancer Xenografts Revealing New Treatment Strategies

Published:2011-05-13 Issue:13 Volume:17 Page:4451-4461
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Faratian Dana,Zweemer Annelien J.M.,Nagumo Yoko,Sims Andrew H.,Muir Morwenna,Dodds Michael,Mullen Peter,Um Inhwa,Kay Charlene,Hasmann Max,Harrison David J.,Langdon Simon P.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual targeting non-overlapping epitopes in HER2 domain IV substantially enhanced HER2/HER2 homodimers and HER2/EGFR heterodimers internalization leading to potent antitumor activity in HER2-positive human gastric cancer;Journal of Translational Medicine;2024-07-09

2. Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients;Journal of Experimental & Clinical Cancer Research;2024-05-15

3. Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies;Journal of Clinical Medicine;2024-03-24

4. Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer;Journal of Experimental & Clinical Cancer Research;2024-02-26

5. Identification of potential target genes of cardiac glycosides from Vernonia amygdalina Delile in HER2+ breast cancer cells;South African Journal of Botany;2024-01